Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.

Publication

Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.

Journal Paper/Review - May 11, 2022

Fischer Tim, El Baz Yassir, Graf Nicole, Wildermuth Simon, Leschka Sebastian, Kleger Gian-Reto, Pietsch Urs, Frischknecht Manuel, Scanferla Giulia, Strahm Carol, Wälti Stephan, Dietrich Tobias, Albrich Werner

Citation

Fischer T, El Baz Y, Graf N, Wildermuth S, Leschka S, Kleger G, Pietsch U, Frischknecht M, Scanferla G, Strahm C, Wälti S, Dietrich T, Albrich W. Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis. Diagnostics (Basel) 2022; 12

Type

Journal Paper/Review (English)

Journal

Diagnostics (Basel) 2022; 12

Publication Date

May 11, 2022

Issn Print

2075-4418

Brief description/objective

COVID-19 superinfection by Aspergillus (COVID-19-associated aspergillosis, CAPA) is increasingly observed due to increased awareness and use of corticosteroids. The aim of this study is to compare clinical and imaging features between COVID-19 patients with and without associated pulmonary aspergillosis.